If that is not feasible, consult your doctor to obtain a new prescription for a suitable dose or a different available medication
Clinical studies have demonstrated 5%-15% weight loss on average in patients using the medication as directed and in the setting of comprehensive support for weight loss
Addressing Muscle Loss Concerns in Weight Loss Treatments A visual representation of muscle preservation during weight loss treatments, relevant to Eli Lillys approach
Roche Holding AG Merck & Co., Inc
It binds to GLP-1 receptors found on: Pancreatic -cells Stimulates glucose-dependent insulin secretion Pancreatic -cells Suppresses glucagon release during hyperglycemia Hypothalamic satiety centers Reduces appetite and food intake Gastrointestinal tract Delays gastric emptying, enhancing satiety This multi-site activity leads to improved glycemic control, reduced body weight, and cardiovascular benefits
Still, the research raises the possibility that the drugs may not lead to long-term savings for insurers and government programs